Brief: Century And Fujifilm Announce Licenses For Development And Commercialization Of IPSC-Derived Cell Therapies In Autoimmune And Inflammatory Diseases
09/11/2023 12:26
Nov 9 (Reuters) - Century Therapeutics Inc IPSC.O :
* CENTURY THERAPEUTICS AND FUJIFILM CELLULAR DYNAMICS
ANNOUNCE
LICENSES FOR DEVELOPMENT AND COMMERCIALIZATION OF IPSC-DERIVED
CELL THERAPIES IN AUTOIMMUNE AND INFLAMMATORY DISEASES
* CENTURY THERAPEUTICS - UNDER TERMS, FUJIFILM CELLULAR
DYNAMICS
WILL BE ELIGIBLE TO RECEIVE CERTAIN DEVELOPMENT AND REGULATORY
MILESTONE PAYMENTS
Source text for Eikon: ID:nGNXcNMhq
Further company coverage: IPSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview